APA (7th ed.) Citation

BK, E., O, N., S, D., A, B., J, T., M, S., . . . AN, F. (2020). Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort study. Gynecologic oncology, 159(1), 17. https://doi.org/10.1016/j.ygyno.2020.07.016

Chicago Style (17th ed.) Citation

BK, Erickson, et al. "Human Epidermal Growth Factor 2 (HER2) in Early Stage Uterine Serous Carcinoma: A Multi-institutional Cohort Study." Gynecologic Oncology 159, no. 1 (2020): 17. https://doi.org/10.1016/j.ygyno.2020.07.016.

MLA (9th ed.) Citation

BK, Erickson, et al. "Human Epidermal Growth Factor 2 (HER2) in Early Stage Uterine Serous Carcinoma: A Multi-institutional Cohort Study." Gynecologic Oncology, vol. 159, no. 1, 2020, p. 17, https://doi.org/10.1016/j.ygyno.2020.07.016.